Breast cancer gene variants: Separating the harmful from the harmless

Journal of Clinical Investigation

Volumn 119, Issue 10, 2009, Pages 2895-2897

  Domchek, Susan M ^a   Greenberg, Roger A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ALLELE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; EARLY CANCER; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; IN VIVO STUDY; MASTECTOMY; NONHUMAN; NOTE; ONCOGENE; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; RISK REDUCTION; TUMOR GENE;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MICE; POLYMORPHISM, GENETIC;

EID: 70349705620     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40577     Document Type: Note

References (21)

1. Antoniou, A., et al. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72:1117-1130. (Pubitemid 36530000)
2. Rebbeck, T.R., et al. 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346:1616-1622. (Pubitemid 34755669)
3. Kauff, N.D., et al. 2002. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 346:1609-1615. (Pubitemid 34755668)
4. Domchek, S.M., et al. 2006. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 7:223-229. (Pubitemid 43286452)
5. Fong, P.C., et al. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361:123-134.
6. Deffenbaugh, A.M., Frank, T.S., Hoffman, M., Cannon-Albright, L., and Neuhausen, S.L. 2002. Characterization of common BRCA1 and BRCA2 variants. Genet. Test. 6:119-121. (Pubitemid 34894240)
7. Domchek, S., and Weber, B.L. 2008. Genetic variants of uncertain significance: flies in the ointment. J. Clin. Oncol. 26:16-17.
8. Jasin, M. 2002. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene. 21:8981-8993. (Pubitemid 36110827)
9. Scully, R., et al. 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:425-435. (Pubitemid 27347233)
10. Sharan, S.K., et al. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 [see comments]. Nature. 386:804-810.
11. Greenberg, R.A., et al. 2006. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev. 20:34-46.
12. Livingston, D.M. 2009. Cancer. Complicated supercomplexes. Science. 324:602-603.
13. Hashizume, R., et al. 2001. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276:14537-14540. (Pubitemid 37373320)
14. Brzovic, P.S., Meza, J.E., King, M.C., and Klevit, R.E. 2001. BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J. Biol. Chem. 276:41399-41406. (Pubitemid 37373302)
15. Chang, S., Biswas, K., Martin, B.K., Stauffer, S., and Sharan, S.K. 2009. Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. J. Clin. Invest. 119:3160-3171.
16. Chandler, J., Hohenstein, P., Swing, D.A., Tessarollo, L., and Sharan, S.K. 2001. Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis. 29:72-77. (Pubitemid 32204223)
17. Hohenstein, P., et al. 2001. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. Oncogene. 20:2544-2550. (Pubitemid 32531351)
18. Xu, X., et al. 2001. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28:266-271. (Pubitemid 32626030)
19. Cortez, D., Wang, Y., Qin, J., and Elledge, S.J. 1999. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286:1162-1166. (Pubitemid 129515811)
20. Tibbetts, R.S., et al. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2989-3002.
21. Kuznetsov, S.G., Liu, P., and Sharan, S.K. 2008. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat. Med. 14:875-881.